MRK
Merck & Co., Inc.
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Merck & Co., Inc. is a healthcare company that makes medicines and vaccines for both people and animals. They create treatments for serious health issues like cancer, diabetes, and infections, and also produce vaccines to help prevent diseases. In addition, Merck develops products to keep animals healthy, including vaccines and medicines for pets and livestock. Founded in 1891, the company is based in New Jersey and works with other organizations to improve health solutions.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Key Business Risks
Meeting Expectations
Higher values indicate better execution and credibility
Recent Results
2025-02-04
2024-10-31
2024-07-30
2024-04-25
2024-02-01
2023-10-26
2023-08-01
2023-04-27
2023-02-02
2022-10-27
Takeaways
Merck & Co., Inc. demonstrates strong business attractiveness due to its diverse pharmaceutical and animal health segments, solid market position, and effective collaborations. However, potential risks from regulatory challenges and competitive pressures temper its overall robustness.
Historical data shows an impressive CAGR compared with the USA stock market average, reflecting a strong market position.
10Y annualized return is
positive but below market average
at 3.3% per year
MRK has met or exceeded earnings expectations in
most
recent quarters (9/10)
Continue with...